| Patsopoulos, NA and de Bakker, PI and Esposito, F and Reischl, J and Lehr, S and Bauer, D and Heubach, J and Sandbrink, R and Pohl, C and Edan, G and Kappos, L and Miller, D and Montalban, J and Polman, CH and Freedman, MS and Hartung, HP and Arnason, BG and Comi, G and Cook, S and Filippi, M and Goodin, DS and Jeffery, D and O'Connor, P and Ebers, GC and Langdon, D and Reder, AT and Traboulsee, A and Zipp, F and Schimrigk, S and Hillert, J and Bahlo, M and Booth, DR and Broadley, S and Brown, MA and Browning, BL and Browning, SR and Butzkueven, H and Carroll, WM and Chapman, C and Foote, SJ and Griffiths, L and Kermode, AG and Kilpatrick, TJ and Lechner-Scott, J and Marriott, M and Mason, D and Moscato, P and Heard, RN and Pender, MP and Perreau, VM and Perera, D and Rubio, JP and Scott, RJ and Slee, M and Stankovich, J and Stewart, GJ and Taylor, BV and Tubridy, N and Willoughby, E and Wiley, J and Matthews, P and Boneschi, FM and Compston, A and Haines, J and Hauser, SL and McCauley, J and Ivinson, A and Oksenberg, JR and Pericak-Vance, M and Sawcer, SJ and De Jager, PL and Hafler, DA, Baya Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNB-1b and a CCR1-Antagonist; ANZgene Consortium; GeneMSA; International Multiple Sclerosis Genetics Consortium, “Genome-Wide Meta-Analysis Identifies Novel Multiple Sclerosis Susceptibility Loci”, Annals of Neurology, 70 (6) pp. 897-912. ISSN 0364-5134 (2011) [Refereed Article] |
